[
  {
    "ts": null,
    "headline": "Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2",
    "summary": "Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. Morgan Stanley boosted its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $255 from $245 on February 6. The firm kept an Overweight rating on the stock. In a research note, the analyst said the firm updated its view […]",
    "url": "https://finnhub.io/api/news?id=5453358f41b49c1816e63fa1b28f03b42e8bd8760a7cdf582b4b0e066688370f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770642304,
      "headline": "Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2",
      "id": 138415898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. Morgan Stanley boosted its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $255 from $245 on February 6. The firm kept an Overweight rating on the stock. In a research note, the analyst said the firm updated its view […]",
      "url": "https://finnhub.io/api/news?id=5453358f41b49c1816e63fa1b28f03b42e8bd8760a7cdf582b4b0e066688370f"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock plunges 27%",
    "summary": "Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.",
    "url": "https://finnhub.io/api/news?id=ac2818a5b38b5c585c327a0d3e0a3b3abd042b37ea0f7b5e0a5857ff8c285e79",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770620417,
      "headline": "Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock plunges 27%",
      "id": 138576324,
      "image": "https://image.cnbcfm.com/api/v1/image/108261299-1770641604537-108261299-17702146372026-02-04t141011z_1036041844_rc20fjavm80v_rtrmadp_0_novo-nordisk-results.jpg?v=1770641619&w=1920&h=1080",
      "related": "MCK",
      "source": "CNBC",
      "summary": "Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages. ",
      "url": "https://finnhub.io/api/news?id=ac2818a5b38b5c585c327a0d3e0a3b3abd042b37ea0f7b5e0a5857ff8c285e79"
    }
  }
]